I now have rich source material for all topics. Let me now compose the complete, comprehensive study notes.
Physiology Study Notes - Complete Review
1. ANS - Sympathetic vs Parasympathetic
Origin (Outflow)
| Feature | Sympathetic | Parasympathetic |
|---|
| Outflow | Thoracolumbar (T1-L2) | Craniosacral (CN III, VII, IX, X + S2-S4) |
| Preganglionic fiber | Short | Long |
| Postganglionic fiber | Long | Short |
| Ganglion location | Paravertebral / prevertebral (far from organ) | Terminal ganglia (in/near organ wall) |
| Neurotransmitter (pre) | ACh (nicotinic) | ACh (nicotinic) |
| Neurotransmitter (post) | NE (adrenergic) | ACh (muscarinic) |
Exception: Adrenal medulla gets direct preganglionic sympathetic fibers (no postganglionic neuron); releases EPI + NE directly into blood.
Functional Effects (Organ by Organ)
| Organ | Sympathetic ("fight or flight") | Parasympathetic ("rest & digest") |
|---|
| Heart rate | Increases (β1) | Decreases (M2) |
| Contractility | Increases (β1) | Slight decrease |
| Bronchi | Dilates (β2) | Constricts |
| GI motility | Decreases (α2, β2) | Increases |
| GI sphincters | Contracts (closes) | Relaxes |
| Pupils | Dilates - mydriasis (α1) | Constricts - miosis (M3) |
| Salivary glands | Thick, viscous saliva (α1) | Watery, profuse saliva |
| Bladder detrusor | Relaxes (β2) | Contracts (M3) |
| Bladder sphincter | Contracts (α1) | Relaxes |
| Blood vessels (skin, viscera) | Constricts (α1) | Minimal direct effect |
| Sweat glands | Activates (cholinergic sympathetic - muscarinic) | - |
| Adrenal medulla | EPI/NE secretion | - |
| Liver | Glycogenolysis (β2, α1) | - |
| Eye (ciliary muscle) | Relaxes (β2) - far vision | Contracts (M3) - near vision |
Key receptors: α1 (vasoconstriction, pupil dilation), α2 (presynaptic inhibition), β1 (heart), β2 (bronchi, blood vessels), M2 (heart), M3 (smooth muscle, glands).
- Histology: A Text and Atlas, p. 988-989
2. Sleep - REM vs NREM
NREM Sleep (Non-Rapid Eye Movement)
NREM has 4 stages (or 3 in newer classification merging stages 3+4):
| Stage | EEG | Features |
|---|
| N1 (Stage 1) | Theta waves (4-7 Hz) | Lightest sleep; hypnic jerks; easily awakened |
| N2 (Stage 2) | Sleep spindles (8-14 Hz) + K complexes | True sleep begins; ~50% of total sleep |
| N3 (Stage 3) | Delta waves (<4 Hz, >20%) | Slow-wave sleep (SWS) / deep sleep |
| N4 (Stage 4) | Delta waves (>50%) | Deepest; GH release; sleepwalking/night terrors |
(Note: Modern AASM classification merges N3+N4 into a single N3 stage)
REM Sleep (Rapid Eye Movement)
- EEG resembles waking state - low voltage, high frequency (beta-like, "desynchronized")
- Rapid eye movements, muscle atonia (paralysis of voluntary muscles via glycine/GABA inhibition)
- Most vivid dreaming occurs here
- Occurs in cycles of ~90 minutes; first REM period is short (~10 min), lengthens toward morning
- Penile/clitoral tumescence (physiological)
- Increased brain O2 consumption
Sleep Architecture
- Total sleep time: ~7-9 hours in adults
- Cycles: 4-6 per night, each ~90 minutes
- Early night: More NREM (deep, slow-wave)
- Late night: More REM
- REM deprivation → REM rebound on recovery nights
Key Neurochemistry
| State | Dominant neurotransmitters |
|---|
| Wake | ACh (high), NE (high), Serotonin (high), Histamine (high) |
| NREM | All aminergic systems decrease; GABA increases |
| REM | ACh (high - REM-on); NE + Serotonin virtually silent (REM-off) |
- Adenosine builds up during wakefulness → sleep pressure (caffeine blocks adenosine receptors)
- SCN (suprachiasmatic nucleus) controls circadian rhythm; melatonin from pineal gland promotes sleep onset
3. EEG Waves ⭐ (Important)
A normal EEG. First seconds show alpha activity (8-13 Hz), largest occipital. At the arrows, subject opened eyes - alpha suppressed, replaced by faster beta rhythms.
EEG Wave Summary Table
| Wave | Frequency | Amplitude | State/Association |
|---|
| Delta (δ) | < 4 Hz | High | Deep NREM sleep (N3/N4); coma; infants; abnormal in awake adults |
| Theta (θ) | 4-7 Hz | Medium | Light sleep (N1); drowsiness; emotional states; normal in children |
| Alpha (α) | 8-13 Hz | Medium | Relaxed, awake, eyes closed; largest over occipital cortex; disappears on eye opening |
| Mu (μ) | 8-13 Hz | Medium | Similar to alpha; over motor/somatosensory cortex; disappears with motor activity |
| Beta (β) | 15-30 Hz | Low | Alert/active thinking; eye opening; mental activity; benzodiazepines increase beta |
| Gamma (γ) | 30-90 Hz | Very low | Activated, attentive cortex; perception binding; cognitive processing |
Sleep-Specific EEG Features
| Feature | Frequency | Stage |
|---|
| Sleep spindles | 8-14 Hz (brief bursts) | N2 (hallmark of N2) |
| K complexes | Nonrhythmic sharp wave + slow wave | N2 (often precedes spindles) |
| Delta waves | <4 Hz (large amplitude) | N3/N4 (slow-wave sleep) |
| Ripples | 80-200 Hz (brief) | Sleep (memory consolidation) |
Clinical Correlates
- 3 Hz spike-and-wave: Absence seizures
- Triphasic waves: Hepatic encephalopathy
- Burst suppression: Deep anesthesia / severe anoxic injury
- Isoelectric (flat) EEG: Brain death criterion
- Alpha coma: Eyes-open coma (poor prognosis)
- Benzodiazepines → increase beta activity
- Barbiturates → increase beta at low doses, burst suppression at high doses
Source: Neuroscience: Exploring the Brain, 5th Ed., p. 1710-1712
4. CSF Formation & Circulation
Formation
- Produced mainly by choroid plexus (lateral, 3rd, 4th ventricles) - ~500 mL/day
- Total volume in CNS: ~150 mL (turns over ~3x/day)
- Mechanism: Active secretion (Na+/K+ ATPase driven) + ultrafiltration of plasma
- Composition: Clear, colorless; low protein (~15-45 mg/dL), glucose ~60% of serum, no cells normally
Circulation Pathway
Lateral ventricles → Foramen of Monro → 3rd ventricle → Cerebral aqueduct (of Sylvius) → 4th ventricle → Foramina of Magendie (median) + Luschka (lateral) → Subarachnoid space → Arachnoid granulations → Superior sagittal sinus → Venous blood
Memory aid: "Monro-Sylvius-Magendie-Luschka"
Absorption
- Primarily via arachnoid granulations (villi) into dural venous sinuses
- Pressure-dependent, unidirectional flow
Clinical Points
- Hydrocephalus: Obstruction of flow (communicating vs non-communicating)
- Normal pressure hydrocephalus: Triad - gait apraxia, dementia, urinary incontinence ("wet, wobbly, wacky")
- Lumbar puncture at L3-L4 or L4-L5 (below spinal cord termination at L1-L2)
5. Hypothalamus Functions
The hypothalamus integrates the neuroendocrine, autonomic, and behavioral systems.
Releasing/Inhibiting Hormones (for Anterior Pituitary)
| Hypothalamic Hormone | Effect on Ant. Pituitary |
|---|
| TRH | Releases TSH, Prolactin |
| CRH | Releases ACTH |
| GnRH | Releases LH, FSH |
| GHRH | Releases GH |
| Somatostatin (SS) | Inhibits GH, TSH |
| Dopamine (PIH) | Inhibits Prolactin |
Other Functions
| Function | Region |
|---|
| Temperature regulation | Anterior hypothalamus (cooling); Posterior (heat conservation) |
| Thirst / osmolarity | Osmoreceptors → ADH release (posterior pituitary) |
| Hunger/Satiety | Lateral (hunger); Ventromedial (satiety - "satiety center") |
| Circadian rhythm | Suprachiasmatic nucleus (SCN) |
| Autonomic control | Posterior = sympathetic; Anterior = parasympathetic |
| Emotion/aggression | Limbic connections |
| Sleep-wake | Lateral hypothalamus (orexin/hypocretin - wakefulness) |
| Posterior pituitary hormones | Synthesizes ADH (vasopressin) and Oxytocin (released from posterior pituitary) |
Memory aid: "TRH CRH GnRH GHRH SS DA"
6. Pituitary Gland
Anterior Pituitary (Adenohypophysis)
Derived from Rathke's pouch (oral ectoderm). Regulated by hypothalamic portal system.
| Hormone | Cell Type | Primary Target | Key Effects |
|---|
| GH | Somatotrophs (most numerous) | Liver → IGF-1 | Growth, lipolysis, anti-insulin |
| TSH | Thyrotrophs | Thyroid | T3/T4 synthesis & release |
| ACTH | Corticotrophs | Adrenal cortex | Cortisol, androgens |
| LH | Gonadotrophs | Gonads | Ovulation (F); testosterone (M) |
| FSH | Gonadotrophs | Gonads | Follicle growth (F); spermatogenesis (M) |
| Prolactin | Lactotrophs | Breast | Lactation; inhibits GnRH |
| MSH | Melanotrophs | Melanocytes | Pigmentation |
Posterior Pituitary (Neurohypophysis)
Derived from neural ectoderm (diencephalon). Stores and releases hormones synthesized in hypothalamus.
| Hormone | Synthesized in | Effect |
|---|
| ADH (Vasopressin) | Supraoptic nucleus | Water reabsorption (collecting duct V2R), vasoconstriction (V1R) |
| Oxytocin | Paraventricular nucleus | Uterine contraction, milk ejection, social bonding |
7. Thyroid Hormones ⭐ (Important)
Synthesis Steps (in thyroid follicle)
- Iodide (I-) uptake - Na+/I- symporter (NIS) on basolateral membrane - stimulated by TSH
- Oxidation: I- → I2 by thyroid peroxidase (TPO) (requires H2O2)
- Organification: Iodination of tyrosine residues on thyroglobulin → MIT (monoiodotyrosine) + DIT (diiodotyrosine)
- Coupling (by TPO):
- MIT + DIT → T3 (triiodothyronine, more active)
- DIT + DIT → T4 (thyroxine, prohormone)
- Storage: As thyroglobulin in follicular lumen (colloid) - the body's largest hormone store
- Release: TSH stimulates proteolysis of thyroglobulin → T3 + T4 secreted
- T4 → T3 conversion in periphery by deiodinase (T3 is 4x more potent)
Antibodies in Hashimoto thyroiditis: Anti-TPO antibodies (diagnostic)
Transport in Blood
- ~99.97% bound to Thyroxine-Binding Globulin (TBG), albumin, transthyretin
- Only free hormone is active and participates in feedback
- T4 half-life: ~7 days; T3 half-life: ~1 day
Mechanism of Action
- Nuclear receptors → gene transcription
- T4 deiodinated to T3 inside cells (T3 is the active form)
- Increases basal metabolic rate, O2 consumption, mitochondriogenesis
- Permissive for catecholamine effects (upregulates β-receptors)
Physiological Effects
| System | Effect |
|---|
| Metabolism | ↑ BMR, ↑ O2 consumption, ↑ heat production |
| Cardiovascular | ↑ HR, ↑ CO, ↑ β-receptor sensitivity |
| Development | Essential for brain development (fetal) + linear growth |
| GI | ↑ Gut motility |
| Bone | ↑ Bone turnover |
| Glucose | ↑ Glucose absorption and glycogenolysis |
Hypothyroidism vs Hyperthyroidism
| Feature | Hypothyroidism | Hyperthyroidism |
|---|
| TSH | ↑ (primary) | ↓ |
| Metabolism | Slow - weight gain, cold intolerance | Fast - weight loss, heat intolerance |
| Heart | Bradycardia | Tachycardia, palpitations |
| GI | Constipation | Diarrhea |
| Skin | Dry, coarse, myxedema | Warm, moist, pretibial myxedema (Graves) |
| Cause | Hashimoto (anti-TPO, anti-Tg) | Graves (TSI/TSH-R antibodies) |
| Treatment | Levothyroxine (T4) | PTU, methimazole, β-blockers, RAI |
Drug Inhibitors of Thyroid Synthesis
- PTU, Methimazole: Block TPO (organification + coupling)
- PTU also: Blocks peripheral T4→T3 conversion
- High-dose iodide (Wolff-Chaikoff): Transiently inhibits organification
- Lithium: Inhibits thyroglobulin proteolysis → blocks T3/T4 release
Source: Lippincott Illustrated Reviews Pharmacology, p. 779-781
8. Insulin & Glucagon
Insulin
- Secreted by β-cells of islets of Langerhans
- Stimulated by: glucose, amino acids, GIP, GLP-1, vagal (ACh), β2-adrenergic
- Inhibited by: hypoglycemia, somatostatin, α2-adrenergic (sympathetic)
- Mechanism: Glucose → ↑ ATP/ADP → closes K+ channels → depolarization → Ca2+ influx → insulin exocytosis
Key Actions:
| Tissue | Effect |
|---|
| Liver | ↑ Glycogen synthesis, ↑ glycolysis, ↓ gluconeogenesis, ↑ lipogenesis |
| Muscle | ↑ Glucose uptake (GLUT4), ↑ glycogen synthesis, ↑ protein synthesis |
| Adipose | ↑ Glucose uptake (GLUT4), ↑ lipogenesis, ↓ lipolysis |
| General | ↓ Blood glucose, ↑ K+ uptake into cells |
GLUT transporters: GLUT4 is insulin-dependent (muscle, fat). GLUT2 is in liver/pancreas (high capacity, low affinity). GLUT1 is constitutive (brain, RBCs).
Glucagon
- Secreted by α-cells
- Stimulated by: hypoglycemia, amino acids (especially alanine), stress, sympathetic stimulation
- Inhibited by: glucose, insulin, somatostatin
Key Actions:
| Tissue | Effect |
|---|
| Liver (primary target) | ↑ Glycogenolysis, ↑ gluconeogenesis, ↑ ketogenesis |
| Adipose | ↑ Lipolysis (↑ FFA for ketogenesis) |
- Acts via Gs → adenylyl cyclase → ↑ cAMP → PKA
- Counter-regulatory hormones: Glucagon, cortisol, epinephrine, GH (all raise blood glucose)
9. Adrenal Cortex Hormones
Three zones - mnemonic: "GFR" = Salt (mineralocorticoids), Sugar (glucocorticoids), Sex (androgens)
| Zone | Hormone | Regulator | Key Actions |
|---|
| Zona Glomerulosa (outer) | Aldosterone | Renin-Angiotensin, ↑ K+ | Na+ retention, K+ excretion, H+ excretion (collecting duct) |
| Zona Fasciculata (middle) | Cortisol | ACTH (CRH) | Anti-inflammatory, gluconeogenesis, protein catabolism, immunosuppression |
| Zona Reticularis (inner) | DHEA, androgens | ACTH | Weak androgens; pubic/axillary hair |
Cortisol Actions (Glucocorticoid)
- ↑ Blood glucose (gluconeogenesis, protein catabolism → amino acids)
- ↑ Lipolysis (central obesity with Cushing)
- Anti-inflammatory: ↓ PLA2 → ↓ arachidonic acid → ↓ prostaglandins + leukotrienes
- Immunosuppressive: ↓ T-cells, ↓ cytokines
- ↑ BP (permissive for catecholamines; some mineralocorticoid activity)
- Inhibits bone formation
Aldosterone
- Primary stimulus: Angiotensin II (via RAAS), hyperkalemia
- Acts on principal cells of collecting duct → ↑ ENaC expression → Na+ reabsorption → water follows → volume expansion
- Also ↑ H+ secretion by intercalated cells → metabolic alkalosis in excess
10. Calcium Homeostasis ⭐ (Important)
Normal serum calcium: 8.5-10.5 mg/dL (ionized: 4.5-5.6 mg/dL)
Three regulators: PTH, Calcitonin, Vitamin D
Parathyroid Hormone (PTH)
- From chief cells of parathyroid glands
- Stimulated by: ↓ Ca2+, ↓ Mg2+, ↓ Vitamin D
- Inhibited by: ↑ Ca2+ (via CaSR - calcium sensing receptor)
Actions (remember: PTH raises Ca, lowers Phos)
| Organ | PTH Effect |
|---|
| Bone | ↑ Osteoclast activity (via osteoblast RANK-L) → Ca2+ + Phosphate released |
| Kidney (PCT) | ↑ Ca2+ reabsorption; ↑ Phosphate excretion (phosphaturic); ↑ 1α-hydroxylase → ↑ Vitamin D activation |
| Kidney (DCT) | ↑ Ca2+ reabsorption |
| GI (indirect) | Via Vitamin D → ↑ Ca2+ absorption |
Net effect: ↑ serum Ca2+, ↓ serum Phosphate
Vitamin D (Calcitriol - 1,25-dihydroxycholecalciferol)
Activation pathway:
- Skin: 7-dehydrocholesterol + UV → Cholecalciferol (D3)
- Liver: D3 → 25-hydroxyvitamin D (storage form; measured clinically)
- Kidney: 25-OH-D → 1,25(OH)2D (calcitriol - active) via 1α-hydroxylase (stimulated by PTH, ↓ Ca2+, ↓ PO4)
Actions:
- ↑ Intestinal Ca2+ + phosphate absorption (via calbindin)
- ↑ Renal Ca2+ + phosphate reabsorption
- ↑ Bone mineralization (at normal Ca levels); can stimulate osteoclasts in excess
- Net: ↑ Ca2+, ↑ Phosphate (both)
Calcitonin
- From parafollicular C-cells of thyroid
- Stimulated by: ↑ Ca2+
- Actions (opposes PTH):
- Inhibits osteoclasts → ↓ bone resorption
- ↑ Renal Ca2+ + phosphate excretion
- Net: ↓ serum Ca2+
- Physiological role is minor in adults; more important in children and during pregnancy/lactation
- Clinical use: Paget's disease, hypercalcemia (short-term)
Summary Table
| PTH | Vitamin D (calcitriol) | Calcitonin |
|---|
| Source | Parathyroid | Kidney (activated) | Thyroid C-cells |
| Stimulus | ↓ Ca2+ | ↓ Ca2+, PTH | ↑ Ca2+ |
| Serum Ca2+ | ↑ | ↑ | ↓ |
| Serum Phosphate | ↓ | ↑ | ↓ |
| Bone | Resorption ↑ | Mineralization ↑ | Resorption ↓ |
| GI absorption | ↑ (indirect) | ↑ (direct) | No effect |
Clinical Points
| Condition | Ca2+ | PO4 | PTH | Notes |
|---|
| Primary hyperPTH | ↑ | ↓ | ↑ | Kidney stones, bones, groans, psychic moans |
| Hypo PTH | ↓ | ↑ | ↓ | Tetany, Chvostek, Trousseau, prolonged QT |
| Vit D deficiency | ↓ (or N) | ↓ | ↑ (secondary) | Rickets (children), Osteomalacia (adults) |
| Malignancy | ↑ | Variable | ↓ | PTHrP or osteolytic mets |
| Sarcoidosis | ↑ | ↑ | ↓ | Macrophages produce 1α-hydroxylase |
| Hypercalcemia Tx | - | - | - | IV fluids, furosemide, bisphosphonates, calcitonin |
Tetany features:
- Chvostek sign: Tap facial nerve → facial twitch
- Trousseau sign: Inflate BP cuff → carpal spasm
Sources: Neuroscience: Exploring the Brain 5th Ed. | Lippincott Illustrated Reviews Pharmacology | Histology: A Text and Atlas | Medical Physiology (Boron & Boulpaep)